(Q34105726)

31 July 2017

1 reference

title

A systems model of altered consciousness: integrating natural and drug-induced psychoses (English)

1 reference

31 July 2017

1 reference

Vollenweider FX

1

1 reference

31 July 2017

Geyer MA

series ordinal

2

1 reference

31 July 2017

language of work or name

1 reference

1 November 2001

1 reference

31 July 2017

Brain Research Bulletin

1 reference

31 July 2017

56

1 reference

31 July 2017

495-507

1 reference

31 July 2017

5

1 reference

Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

The role of the thalamus in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

"Cognitive dysmetria" as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry?

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Metabotropic glutamate receptors: electrophysiological properties and role in plasticity

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Light and electron microscopic evidence for a GABAergic projection from the caudal basal forebrain to the thalamic reticular nucleus in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist dizocilpine.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

"Psychedelic" Experiences in Acute Psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Sensorimotor gating and schizophrenia. Human and animal model studies

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Prestimulus effects on human startle reflex in normals and schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Patterns of metabolic activity in the treatment of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Striatal metabolic rate and clinical response to neuroleptics in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

PET and MRI of the thalamus in never-medicated patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Schizophrenia: a subcortical neurotransmitter imbalance syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

The Early Symptoms of Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Determination of the transfer ratio of cat's geniculate neurons through quasi-intracellular recordings and the relation with the level of alertness.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Neuronal phenomena associated with vigilance and consciousness: from cellular mechanisms to electroencephalographic patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Ketamine and the conscious mind.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Function of the thalamic reticular complex: the searchlight hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Increased temporal lobe glucose use in chronic schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

The standardized psychometric assessment of altered states of consciousness (ASCs) in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Left globus pallidus abnormality in never-medicated patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Hypofrontality revisited: a high resolution single photon emission computed tomography study in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Dreams, Hallucinogenic Drug States, and Schizophrenia: A Psychological and Biological Comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Early subjective experiences in schizophrenic episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Behavioral studies of hallucinogenic drugs in animals: implications for schizophrenia research.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Startle habituation and sensorimotor gating in schizophrenia and related animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Startle response models of sensorimotor gating and habituation deficits in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Habituation of tactile startle is altered by drugs acting on serotonin-2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Hallucinogenic drug induced states resemble acute endogenous psychoses: results of an empirical study

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

NR2B-containing NMDA receptors are up-regulated in temporal cortex in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Alterations in the cortical serotonergic system in schizophrenia: a postmortem study.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Cholinergic innervation of the human thalamus: Dual origin and differential nuclear distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Models of experience and behavior in psychotic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: experimental psychosis as a tool for psychiatric research.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Blood flow and cerebral laterality in the mescaline model of psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

[Significance of model psychoses]

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

[Relations of model and drug-induced psychoses to schizophrenic diseases]

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics: evidence for glutamate hypothesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Preliminary evidence of an association between sensorimotor gating and distractibility in psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

(3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Modulation of phencyclidine-induced changes in locomotor activity and patterns in rats by serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Ketamine activates psychosis and alters limbic blood flow in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Patterns of cerebral blood flow in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Serotonergic basis of antipsychotic drug effects in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Dopaminergic stimulation disrupts sensorimotor gating in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Indoleamine and the phenethylamine hallucinogens: mechanisms of psychotomimetic action.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Symptom differences in schizophrenia with good and poor prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Disorders of attention and perception in early schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

The role of serotonin in schizophrenia and the place of serotonin-dopamine antagonist antipsychotics.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Visual pathways to perception and action

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Brain stem reticular formation and activation of the EEG

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

The attention system of the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Ego-psychopathology: the concept and its empirical evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

15O positron emission tomographic scanning in predominantly never-treated acute schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Deficient NMDA-mediated glutamate release from synaptosomes of schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Functional organization of thalamocortical relays

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

The control of retinogeniculate transmission in the mammalian lateral geniculate nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

A functional neuroanatomy of hallucinations in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Control of thalamic transmission by corticofugal and ascending reticular pathways in the visual system

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

DOI disrupts prepulse inhibition of startle in rats via 5-HT2A receptors in the ventral pallidum

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

The functional neuroanatomy of awareness: with a focus on the role of various anatomical systems in the control of intermodal attention

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

GABAergic interneurons in the somatosensory thalamus of the guinea-pig: a light and ultrastructural immunocytochemical investigation.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Reticularis thalami neurons revisited: activity changes during shifts in states of vigilance

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Thalamocortical oscillations in the sleeping and aroused brain

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Cholinergic and non-cholinergic neurons of cat basal forebrain project to reticular and mediodorsal thalamic nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

The neural substrates of sensorimotor gating of the startle reflex: a review of recent findings and their implications

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Towards a cross-species pharmacology of sensorimotor gating: effects of amantadine, bromocriptine, pergolide and ropinirole on prepulse inhibition of acoustic startle in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia research.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG).

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

The syndrome concept: history and statistical operationalizations.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900646-3

7 January 2021

10.1016/S0361-9230(01)00646-3

Identifiers

DOI

1 reference

release_q7llf5xnybcidlm2svn2catovi

31 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/q7llf5xnybcidlm2svn2catovi

24 November 2022

mapped directly with Wikidata item

1 reference